Conditions: Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 36
Healthy volunteers: yes

Brief summary:
The purpose of this study is to demonstrate bioequivalence of coadministered drugs on healthy subjects.

Detailed description:

Arms:
arm 1: Single oral dose of saxagliptin tablet coadministered with dapagliflozin tablet arm 2: Single oral dose of FDC (fixed-dose combination) tablet

Interventions: intervention 1: Saxagliptin intervention 2: Dapagliflozin
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: